Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Emmaus Life Sciences, Inc. | s102374_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Emmaus Life Sciences, Inc. | s102374_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - Emmaus Life Sciences, Inc. | s102374_ex32-1.htm |
| EX-3.1.3 - EXHIBIT 3.1.3 - Emmaus Life Sciences, Inc. | s102374_ex3-1x3.htm |
| EX-10.26 - EXHIBIT 10.26 - Emmaus Life Sciences, Inc. | s102374_ex10-26.htm |
| EX-10.25 - EXHIBIT 10,25 - Emmaus Life Sciences, Inc. | s102374_ex10-25.htm |
| 10-K - 10-K - Emmaus Life Sciences, Inc. | s102374_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - Emmaus Life Sciences, Inc. | s102374_ex32-2.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders
of MYnd Analytics, Inc.
85 Enterprise, Suite 410
Aliso Viejo, CA 92656
We hereby consent to the incorporation by reference in the Registration Statement on Form S8 No. 333-166394 of CNS Response, Inc. of our report dated January 5, 2016, relating to the consolidated financial statements which appear in this Form 10-K .
| /s/ Anton & Chia, LLP | |
| Newport Beach, California | |
| January 5, 2016 |